LLY compared with COGT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

COGTCogent Biosciences, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

COGTCogent Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

COGT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.6%▼−2.03%×0.21

Q1 FY26±9.5%▲+0.68%×0.07

= impliedLLY realized, solidCOGT realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

Feb 17 '26

±7.5%

▲+2.98%

×0.40

Q3 FY25±37.0%▼−4.91%×0.13

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

COGTCogent Biosciences, Inc.

29.54▼−6.18%· post 29.21

ClosedNov 5 '26

Mkt cap$5.1BRevenue—Revenue—

Compare

ClosedNov 5 '26

LLYELI Lilly & Co

COGTCogent Biosciences, Inc.

1,371.32▼−3.29%post 1,363.77

Price

29.54▼−6.18%post 29.21

$1.2T

Mkt cap

$5.1B

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,371.32▼−3.29%vsCOGT29.54▼−6.18%ClosedNov 5 '26